Kairos PharmaKAPA
13F holders, Q4 2024 (December 31)5holders +3
4new positions
1sold out
1famous investor
$1.52avg. 13F price*
At the end of Q4 2024, 5 institutions reported holding Kairos Pharma Ltd. (KAPA) in their 13F filings, up 3 from Q3 2024. 4 opened new positions and 1 sold out. The largest holders were UMB Bank, n.a. ($564K), Virtu Financial LLC ($21K) and Citadel Advisors ($17K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Kairos Pharma Ltd.
- CUSIP
- 48301N104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $597K |
| Exits | 1 | $19K |
All 13F filers, Q3 2024 → Q4 2024: 392,942 shares bought and 31,664 shares sold, net +361,278 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| UMB Bank, n.a. | 0.01% | New | 371,115 | $564K |
| Virtu Financial LLC | 0.00% | Reduce -58.3% | 13,656 | $21K |
| Citadel Advisors | 0.00% | New | 10,969 | $17K |
| UBS Group AG | 0.00% | New | 10,845 | $16K |
| Bank of America Corp. | 0.00% | New | 13 | $20 |
"% of holder's portfolio" is KAPA's weight in each manager's 13F, not the share of Kairos Pharma Ltd. the manager owns.